Top Wall Street analysts find these 3 stocks attractive as long-term investments

Wall Street analysts highlighted Oracle, Rocket Lab and Meta as long-term growth opportunities, primarily tied to AI infrastructure, cloud demand and space-sector monetization. Guggenheim expects Oracle's IaaS growth to exceed its Q1 FY27 120% constant-currency rate and set a $400 target, while Raymond James initiated Rocket Lab at buy with an $80 target, forecasting 59% revenue growth in 2026 and nearly $2.4B of backlog. J.P. Morgan upgraded Meta to buy and raised its target to $820 from $640, citing its frontier AI models, AI products and distribution to roughly 4 billion users.

Analysis

ORCL’s re-rating depends less on booked AI demand than on conversion of contracted capacity into billable utilization. The near-term risk is that power, networking, and GPU-delivery bottlenecks defer revenue recognition while depreciation and financing costs begin immediately, producing a temporary FCF and margin disconnect. Customer concentration is improving directionally, but the relevant diligence item is whether new commitments are economically comparable to the anchor tenant contracts; lower pricing or unusually favorable cancellation terms would dilute the apparent backlog quality.

META offers the cleaner 6-18 month AI risk/reward because its core advertising engine can fund model investment, while distribution can turn incremental engagement, business messaging, and creator tools into monetization without requiring an enterprise-sales buildout. Consensus may underappreciate that successful consumer AI also raises inference expense: the upside case requires ad-ranking/conversion gains and new paid products to outpace compute costs. The key 1-3 month catalyst is evidence of sustained ad pricing and engagement improvement alongside capex guidance that does not move materially higher.

RKLB is a higher-beta execution trade rather than a conventional cash-flow compounder. The strategic logic of vertical integration is attractive, but the valuation will remain dominated by Neutron schedule certainty, launch reliability, financing needs, and integration of any acquired spectrum/constellation assets; a delay can push expected operating leverage out several years. The non-obvious beneficiary of credible medium-lift progress is the broader defense-space complex, including LHX and NOC, as government customers seek resilient launch, communications, and satellite capacity rather than a single-provider architecture.

The consensus error is treating all AI-linked infrastructure as equivalent. ORCL must prove return on a capital-intensive buildout, while META can demonstrate AI returns through relatively frequent advertising KPIs; therefore, a relative META-over-ORCL position is more robust if rates rise or AI spending faces an ROI reset. This view is falsified if ORCL shows multiple consecutive quarters of capacity activation with expanding cloud gross margin and cash conversion, or if META’s capex rises faster than advertising monetization.

Key Decisions for Investors

• Initiate a 6-12 month pair: long META / short ORCL in equal dollar amounts. META has a more self-funded AI monetization path; ORCL carries greater capacity-timing and financing sensitivity. Reassess if ORCL reports two quarters of cloud growth acceleration with stable-to-improving FCF conversion, or META’s ad-growth premium versus peers compresses materially.
• Add META on post-earnings weakness only if incremental capex guidance is contained and ad-impression or pricing trends remain intact; use a 10-12% downside stop from entry. Base case is multiple support from earnings revisions over the next two reporting cycles, while the principal risk is inference costs absorbing the productivity benefit.
• Treat RKLB as a catalyst watch rather than a full-size core long until independently verified Neutron milestones, acquisition financing terms, and pro forma leverage are available. If milestones remain on schedule, consider a 12-18 month call spread rather than stock to cap downside from schedule slippage; exit on material launch-date deferral, equity financing, or backlog conversion weakness.
• For ORCL, wait for evidence that delivered capacity is translating into revenue rather than only contracted demand before adding exposure. A long position is justified only after cloud-margin and cash-flow disclosure confirms favorable unit economics; otherwise, use ORCL as the short leg against META or a diversified software basket.